Join to View Full Profile
1700 Riverfront CtrAmsterdam, NY 12010
Phone+1 518-843-0020
Fax+1 518-843-0023
Dr. Tedesco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
University of MichiganResidency, Internal Medicine, 1998 - 2001
SUNY Upstate Medical UniversityClass of 1998
Certifications & Licensure
NY State Medical License 2004 - 2025
TN State Medical License 2001 - 2004
MI State Medical License 1998 - 2001
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01
- Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsCirculating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.Costanza Paoletti, Meredith M. Regan, Samuel M. Niman, Emily M. Dolce, Elizabeth P. Darga
NPJ Breast Cancer. 2021-06-11 - 4 citationsPhase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.John W. Smith, Amy Irwin, Lori Jensen, Karen L. Tedesco, Soamnauth Misir
Clinical Breast Cancer. 2020-04-01 - 9 citationsAn open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.Jeffrey L. Vacirca, Arlene Chan, Klára Mezei, Clarence S. Adoo, Zsuzsanna Pápai
Cancer Medicine. 2018-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
